Trastuzumab deruxtecan (Enhertu) significantly improved PFS compared with standard of care as a first-line treatment for HER2-mutant nonsquamous NSCLC. Topline results were announced from the phase 3 ...

The phase 3 ALKIVIA study met its primary endpoint, demonstrating significant and sustained improvements in disease activity and muscle strength for patients with active autoimmune myositis.

In a special episode of the MPR Weekly Dose podcast, Dr William Schaffner — professor of preventive medicine and infectious diseases at Vanderbilt University School of Medicine and former CDC Epidemic ...

States are moving faster and further than federal regulators to get kratom off store shelves, with some banning the herb outright while a pending federal rule targets only one of its chemicals.

The device enables eligible adult wheelchair users living with spinal cord injury to walk and perform some activities of daily living.

Accelerated FDA approval of the first-in-class CELMoD agent iberdomide (Zenbexus) offers a new oral option for adults with relapsed or refractory multiple myeloma.

MHT use linked to significantly lower odds of clinical dementia diagnoses and symptoms of memory/functional decline ...

Administration of dexamethasone eye drops reduces the proportion of preterm infants with prethreshold retinopathy of prematurity (ROP) progressing to type 1 ROP ...

HealthDay News — A new executive order calls for American children to be routinely immunized against 11 diseases instead of the 17 now recommended by federal health officials. President Donald Trump ...

Thirteen conditional recommendations developed, including in relation to guiding therapy during exacerbations.

Prespecified primary analyses showed significant improvement over placebo in patients aged 71 and older and those with a baseline 6MWD below 333 meters.

HealthDay News — A multistate outbreak of Salmonella infections has been linked to fresh jalapeño peppers imported from Sinaloa, Mexico, according to federal health officials.